Clinical Trials Browser

SNX-5422 × Thoracic × Clear all

NCT01851096 2016-08-16

Safety and Pharmacology Study of SNX-5422 in Subjects With Resistant Lung Adenocarcinoma

Phase 1 Completed

Adenocarcinoma of Lung, Neoplasms